Assessing Carotid Revascularization Should We Abandon the Neurological Examination?⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology. by Yadav, Jay S.
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ssessing Carotid
evascularization
hould We Abandon the
eurological Examination?*
ay S. Yadav, MD, FACC
tlanta, Georgia
arotid stenting has become the treatment of choice in
atients who need carotid endarterectomy (CEA) but are at
igh surgical risk (1,2). Concern remains about the inci-
ence of stroke, particularly in the community hospital
etting and in certain patient groups, particularly the elderly
nd symptomatic patients (3). Clearly, there is a need to
ake carotid revascularization, be it endarterectomy or
tenting, safer. A blood test for stroke that is analogous to
roponin or creatine phosphokinase-myocardial band for the
eart would be ideal; the blood-brain barrier has posed a
ignificant challenge and as yet none of these tests has been
ound acceptable (4,5).
See page 571
In this issue of JACC: Cardiovascular Interventions,
chofer et al. (6) report on the use of serial diffusion
eighted (DW) magnetic resonance imaging (MRI) as a
urrogate marker for brain ischemia during carotid stenting.
hey are to be congratulated on continuing their previous
ork in this important area (7). They studied 59, mostly
symptomatic (86%), consecutive patients undergoing pro-
ected carotid stenting and performed sequential DW MRI
cans after the procedure. One type of emboli prevention
evice (Emboshield, Abbott Laboratories, Abbott Park,
llinois) and 1 type of stent (Acculink, Abbott Laboratories)
ere used in the vast majority of cases. Clopidogrel (75
g/day) was given for 3 days prior to the procedure or
lternatively 600 mg was given immediately before the
rocedure.
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
From the Piedmont Heart Institute, Piedmont Hospital, Atlanta, Georgia. Dr.
adav has been a consultant to Cordis and Abbott. Dr. Yadav was a shareholder in
ngioguard, Inc. at the time of its purchase by Johnson & Johnson in 1999. Hew
eceives recurring payments from Johnson & Johnson as a former shareholder of
ngioguard, Inc. He does not own any shares of stock in Johnson & Johnson.None of the patients suffered a stroke or transient
schemic attack. Twelve (20.3%) patients had lesions, all
psilateral, on the initial diffusion weighted imaging (DWI)
can, and 10 patients had lesions on the second scans, with
of these patients having had normal initial scans. In total,
9 of 59 (32%) patients had a lesion on 1 of the MRI
tudies. Interestingly, of the abnormal delayed scans, 4 of
he 10 lesions were in the contralateral hemisphere. The
esions were very small, mean 0.29 mm2 for the first scan
nd 0.37 mm2 for the second scan, and typically only 1
esion was present in a patient.
This is 1 of the few studies to do sequential scans and
rovides valuable insights into the timing of brain ischemia.
here are, however, some methodological concerns that
ffect the interpretation of these results. Clopidogrel dosing
mmediately prior to the procedure may not allow sufficient
ime for platelet inhibition and may lead to increased
icroembolization; at least 2 h are needed to obtain
dequate platelet inhibition after a 600-mg loading dose (8).
heir practice of not pre-dilating prior to stent placement
ay also contribute to increased embolization as the stent is
orced through the lesion.
Interestingly, the filter used in this study has 1 of the
argest pore sizes, 140 m, and the stent used has 1 of the
argest cell sizes, 11.48 mm2 (9). The pivotal study of the
cculink stent did not use this filter; it used the Accunet
lter, which has a substantially smaller pore size (10). It may
ell be that combining the filter with the largest pore size
ith the stent with the largest cell size created a “perfect
torm” leading to high rates of microembolization. It is
mportant to think of carotid devices as systems, because the
ivotal studies were all done with a single filter and a single
tent; the results of these trials may not be reproducible if
arious devices are combined, particularly if the devices have
imilar shortcomings, which may lead to an amplification of
hat deficiency.
Diffusion weighted imaging (DWI) measures the appar-
nt coefficient of distribution of water, which becomes
educed in minutes after the onset of ischemia. Diffusion
eighted imaging is a measure of ischemia, not infarction.
ost small lesions indicated by DWI are not present on
epeat MRI scanning several weeks later. In a study of 105
arotid stenting patients, 22 (21%) of the patients demon-
trated 64 new lesions at 24 h after the procedure and at 6
onths, 62 had resolved (11). The 2 lesions that did not
esolve were the only ones also visible on T2-weighted MRI.
he assumption is that lesions indicated by DWI are due to
icroembolization, but in 1 study there was no correlation
etween the number of microembolic signals on transcranial
oppler (TCD) and the number of lesions on DW MRI
12).
To help put the incidence of lesions indicated by DWI
hat were reported by Schofer et al. (6) in perspective, it is
orthwhile to look at the incidence of lesions indicated by
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579WI in some other common procedures. Diagnostic cere-
ral angiography had a higher incidence (26%) of lesions
ndicated by DWI than neurointerventional procedures
18%); this was felt to be due to heparinization during the
nterventional procedures (13). Addition of heparin and the
se of air filters dramatically reduced the number of lesions
ndicated by DWI (14). Carotid endarterectomy has been
ssociated with lesions indicated by DWI in 4% to 34% of
atients (15,16). Cardiac surgery is associated with DWI
revalence post-operatively in 31% to 47% of patients
17,18). Even coronary angiography is associated with
esions in 14% to 15% of patients and crossing the aortic
alve increases the prevalence of lesions to 22% (19,20).
Diffusion weighted MRI appears to be a very sensitive
ool for detecting even minor cerebral ischemia, but it
orrelates poorly with clinical events. There has been spec-
lation that these clinically silent lesions may, however,
esult in cognitive deficits that require neuropsychological
esting for detection. The CAVATAS (Carotid and Verte-
ral Transluminal Angioplasty Study) trial has been the
nly randomized study of CEA versus carotid angioplasty/
tenting to perform neuropsychological testing in even a
ubset of patients (21). No difference was found between the
EA and angioplasty arms, even though emboli protection
as not used during the carotid interventions.
The findings on DW MRI should not be disregarded,
owever, and can provide a very sensitive marker to help us
urther improve carotid stenting. Certainly, substantial im-
rovements could be made in access devices and techniques.
imilarly, although the current generation of filters is more
perator friendly, it is clear from the results in the elderly
nd symptomatic patients that capture efficiency needs to
mprove. An additional filter during stent dilation may be a
traightforward technique to dramatically improve capture
fficiency during the critical portion of the procedure.
iffusion weighted MRI should be used as a research tool to
ncrease our understanding of carotid intervention and other
edical procedures, but it cannot replace clinical end points
n randomized trials.
eprint requests and correspondence: Dr. Jay S. Yadav, Pied-
ont Heart Institute, 387 Technology Circle NW, Suite 500,
tlanta, Georgia 30313. E-mail: jyadav@cardiomems.com.
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